A new study has found that the poor efficacy of flu vaccines can be as a result of poor immune response and a patient’s wider immune history. In 2012-13, the H3N2 component of the annual flu vaccine was shown to be effective in only 39% of patients, an issue that was at first attributed to
A patch developed by researchers at the Georgia Institute of Technology in collaboration with Emory University is deemed to be an effective alternative to needle-and-syringe immunisation. The patch contains tiny needles that painlessly deliver the flu vaccine into the skin. This new delivery method could lead to a new way of receiving and distributing the
A collaboration between researchers from Emory University in Atlanta and researchers from the Rajiv Gandhi Center for Biotechnology in India, have discovered that mucus produced by a certain frog (Hydrophylax bahuvistara) was able to destroy the influenza virus. The frog in question is native to Southern India, and has found to be able to kill
